Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS.
Paola BrunMelania ScarpaChiara MarchioriGloria SarasinValentina CaputiAndrea PorzionatoMaria Cecilia GironGiorgio PalùIgnazio CastagliuoloPublished in: PloS one (2017)
S. boulardii CNCM I-745 ameliorated gastrointestinal neuromuscular anomalies in a mouse model of gut dysfunctions typically observed with irritable bowel syndrome.